Pentamidine
Based on 9 publication(s) in Google Scholar
Pentamidine (MP-601205) is an antimicrobial agent and interferes with DNA biosynthetics. Pentamidine inhibits parasite Leishmania infantum with an IC50 of 2.5 μM. Pentamidine is a potent and selective protein tyrosine phosphatases (PTPases) and phosphatase of regenerating liver (PRL) inhibitor. Pentamidine has the potential for Gambian trypanosomiasis, antimony-resistant leishmaniasis, and Pneumocystis carinii pneumonia treatment. Antitumor and antibacterial activities.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté: 97.19%
- CAS No.: 100-33-4
- Formule: C19H24N4O2
- Masse moléculaire:340.42
-
Stockage:
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
Publications Citing Use of MedChemExpress (MCE) Pentamidine
More- Nature. 2026 Jul;655(8121):240-250. [Abstract]
- Immunity. 2023 Feb 14;56(2):272-288.e7. [Abstract]
- Drug Des Devel Ther. 2021 Jul 1;15:2857-2868. [Abstract]
- Int J Mol Sci. 2023 Sep 7;24(18):13812. [Abstract]
- Molecules. 2020 Apr 23;25(8):1980. [Abstract]
- Cell Rep Methods. 2023 Oct 23;3(10):100599. [Abstract]
- Microbiol Spectr. 2023 Jun 15;11(3):e0313822. [Abstract]
- BMC Womens Health. 2022 Nov 24;22(1):470. [Abstract]
- Biochem Biophys Res Commun. 2019 Sep 17;517(2):221-226. [Abstract]
-
IF
-
Cell Proliferation/Viability Assay
-
Cell Migration/Invasion Assay
-
WB
-
RT-PCR
Voir tous les produits spécifiques à Isoform Parasite
MoreVoir tous les produits spécifiques à Isoform Antibiotic
More
Activité biologique
|
Trypanosoma |
Leishmania |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| 786-0 | IC50 |
>100 μM
Compound: PEN
|
Cytotoxicity against human 786-O cells assessed as decrease in mitochondrial viability after 6 hrs by CMXRos staining based assay
Cytotoxicity against human 786-O cells assessed as decrease in mitochondrial viability after 6 hrs by CMXRos staining based assay
|
[PMID: 29407968] |
| 786-0 | IC50 |
>25 μM
Compound: PEN
|
Mitochondrial toxicity in human 786-O cells measured after 6 hrs by MitoTracker Red chloromethyl-X-rosamine based assay
Mitochondrial toxicity in human 786-O cells measured after 6 hrs by MitoTracker Red chloromethyl-X-rosamine based assay
|
[PMID: 30908048] |
| A549 | GI50 |
>100 μM
Compound: Pentamidine
|
Cytotoxicity against human A549 cells assessed as cell growth by Cell titer-Glo assay
Cytotoxicity against human A549 cells assessed as cell growth by Cell titer-Glo assay
|
[PMID: 28064141] |
| A549 | GI50 |
>25 μM
Compound: PEN
|
Cytotoxicity against human A549 cells after 48 hrs by Celltiter-glo assay
Cytotoxicity against human A549 cells after 48 hrs by Celltiter-glo assay
|
[PMID: 30908048] |
| A549 | IC50 |
>100 μM
Compound: PEN
|
Cytotoxicity against human A549 cells after 48 hrs by CellTiter-Glo assay
Cytotoxicity against human A549 cells after 48 hrs by CellTiter-Glo assay
|
[PMID: 29407968] |
| A549 | IC50 |
23.5 μM
Compound: Pentamidine
|
Cytotoxicity against human A549 cells assessed as decrease in cell viability after 24 to 72 hrs by ATP-based luciferin-luciferase assay
Cytotoxicity against human A549 cells assessed as decrease in cell viability after 24 to 72 hrs by ATP-based luciferin-luciferase assay
|
[PMID: 30108719] |
| A549 | IC50 |
24 μM
Compound: 1
|
Cytotoxicity against A549 cell line
Cytotoxicity against A549 cell line
|
[PMID: 15357989] |
| A549 | IC50 |
24 μM
Compound: Pentamidine
|
Cytotoxicity against human A549 cells
Cytotoxicity against human A549 cells
|
[PMID: 19736009] |
| A549 | IC50 |
40 nM
Compound: 2 (pentamidine)
|
Cytotoxicity against human lung cell carcinoma A549 cell line
Cytotoxicity against human lung cell carcinoma A549 cell line
|
[PMID: 15115412] |
| Astrocyte | EC50 |
1.995 μM
Compound: 32
|
Antiproliferative activity against mouse astrocyte cells by MTT assay
Antiproliferative activity against mouse astrocyte cells by MTT assay
|
[PMID: 17417631] |
| Calu-3 | CC50 |
450 μM
Compound: Pentamidine
|
Cytotoxicity against human Calu-3 cells assessed as reduction in cell viability
Cytotoxicity against human Calu-3 cells assessed as reduction in cell viability
|
[PMID: 37284689] |
| CHO | IC50 |
38 μM
Compound: 4, Pentacarinat, Nebupent, Pentam
|
Inhibition of mouse hippocampal neurons ASIC transfected in CHO cells assessed as inhibition of acid-evoked current at -60 mV holding potential by two-electrode voltage-clamp electrophysiology assay
Inhibition of mouse hippocampal neurons ASIC transfected in CHO cells assessed as inhibition of acid-evoked current at -60 mV holding potential by two-electrode voltage-clamp electrophysiology assay
|
[PMID: 24630693] |
| HEK293 | CC50 |
>4 μM
Compound: Pentamidine
|
Cytotoxicity against human HEK293 cells assessed as reduction in cell viability at 20 uM measured after 48 hrs by resazurin reagent based multilabel reader analysis
Cytotoxicity against human HEK293 cells assessed as reduction in cell viability at 20 uM measured after 48 hrs by resazurin reagent based multilabel reader analysis
|
[PMID: 36608774] |
| HEK293 | CC50 |
0.67 μM
Compound: Pentamidine
|
Cytotoxicity against human HEK293 cells assessed as reduction in cell viability measured after 48 hrs by resazurin assay
Cytotoxicity against human HEK293 cells assessed as reduction in cell viability measured after 48 hrs by resazurin assay
|
[PMID: 33479668] |
| HEK293 | EC50 |
>100 μM
Compound: Pentamidine
|
Cytotoxicity against HEK293 cells assessed as reduction in cell viability after 48 hrs by alamar blue assay
Cytotoxicity against HEK293 cells assessed as reduction in cell viability after 48 hrs by alamar blue assay
|
[PMID: 27720295] |
| HEK293 | IC50 |
1.2 μM
Compound: pentamidine
|
Inhibition of human OCT2-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay
Inhibition of human OCT2-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay
|
[PMID: 23241029] |
| HEK293 | IC50 |
10.4 μM
Compound: pentamidine
|
Inhibition of human MATE2K-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay
Inhibition of human MATE2K-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay
|
[PMID: 23241029] |
| HEK293 | IC50 |
2 μM
Compound: pentamidine
|
Inhibition of human MATE1-mediated [14]-metformin uptake expressed in HEK293 cells after 1.5 mins by scintillation counting analysis
Inhibition of human MATE1-mediated [14]-metformin uptake expressed in HEK293 cells after 1.5 mins by scintillation counting analysis
|
[PMID: 23241029] |
| HEK293 | IC50 |
2.7 μM
Compound: pentamidine
|
Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay
Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay
|
[PMID: 23241029] |
| HEK293 | IC50 |
2.7 μM
Compound: pentamidine
|
Inhibition of human MATE2K-mediated ASP+ uptake expressed in HEK293 cells up to 500 uM after 1.5 mins by fluorescence assay
Inhibition of human MATE2K-mediated ASP+ uptake expressed in HEK293 cells up to 500 uM after 1.5 mins by fluorescence assay
|
[PMID: 23241029] |
| HEK293 | IC50 |
22.1 μM
Compound: pentamidine
|
Inhibition of human OCT1-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay
Inhibition of human OCT1-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay
|
[PMID: 23241029] |
| HEK293 | IC50 |
71 μM
Compound: Pentamidine
|
Cytotoxicity against human HEK293 cells after 48 hrs by by alamar blue assay
Cytotoxicity against human HEK293 cells after 48 hrs by by alamar blue assay
|
[PMID: 21705225] |
| HEK293 | IC50 |
9.5 μM
Compound: pentamidine
|
Inhibition of human OCT3-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay
Inhibition of human OCT3-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay
|
[PMID: 23241029] |
| HeLa | IC50 |
0.005 μM
Compound: Pentamidine
|
Antitrypanosomal activity against bloodstream trypomastigote form of Trypanosoma brucei brucei 65.3 infected in human HeLa cells after 72 hrs by Alamar Blue assay
Antitrypanosomal activity against bloodstream trypomastigote form of Trypanosoma brucei brucei 65.3 infected in human HeLa cells after 72 hrs by Alamar Blue assay
|
[PMID: 27912173] |
| HeLa | IC50 |
15 μM
Compound: Pentamidine
|
Cytotoxicity against human HeLa cells after 96 hrs by resazurin-based spectrofluorimetric method
Cytotoxicity against human HeLa cells after 96 hrs by resazurin-based spectrofluorimetric method
|
[PMID: 23164660] |
| HepG2 | CC50 |
2.3 μM
Compound: Pentamidine
|
Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay
Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay
|
[PMID: 22608675] |
| HepG2 | CC50 |
2.3 μM
Compound: Pentamidine
|
Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay
Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay
|
[PMID: 24080103] |
| HepG2 | CC50 |
2.3 μM
Compound: Pentamidine
|
Cytotoxicity against human HepG2 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Cytotoxicity against human HepG2 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 25559208] |
| HepG2 | CC50 |
2.3 μM
Compound: Pentamidine
|
Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay
Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay
|
[PMID: 25846065] |
| HepG2 | CC50 |
2.3 μM
Compound: Pentamidine
|
Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay
Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay
|
[PMID: 30655943] |
| HepG2 | CC50 |
2.3 μM
Compound: Pentamidine, Pentacarinat
|
Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay
Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay
|
[PMID: 24858543] |
| HepG2 | IC50 |
159.71 μM
Compound: Pentamidine
|
Cytotoxicity against human HepG2 cells by MTT assay
Cytotoxicity against human HepG2 cells by MTT assay
|
[PMID: 24630563] |
| Huh-7 | CC50 |
>6.25 μM
Compound: GNF-Pf-3680
|
NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)
NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)
|
[PMID: 18579783] |
| J774 | IC50 |
20.43 μM
Compound: Pentamidine
|
Antileishmanial activity against Leishmania donovani (MHOM/IN/Dd8) amastigote infected in mouse J774 cells assessed as after 72 hrs by luminometry
Antileishmanial activity against Leishmania donovani (MHOM/IN/Dd8) amastigote infected in mouse J774 cells assessed as after 72 hrs by luminometry
|
[PMID: 20371140] |
| J774 | IC50 |
46 μM
Compound: P
|
Selectivity index, ratio of IC50 for mouse J774 cells to IC50 for Leishmania amazonensis amastigotes infected in BALB/c mouse macrophages
Selectivity index, ratio of IC50 for mouse J774 cells to IC50 for Leishmania amazonensis amastigotes infected in BALB/c mouse macrophages
|
[PMID: 22000949] |
| J774 | IC50 |
70 μM
Compound: P
|
Cytotoxicity against mouse J774 cells after 72 hrs by MTT assay
Cytotoxicity against mouse J774 cells after 72 hrs by MTT assay
|
[PMID: 22000949] |
| J774.1 | CC50 |
1 μM
Compound: Pentamidine
|
Cytotoxicity against mouse J774.1 cells after 72 hrs by MTT assay
Cytotoxicity against mouse J774.1 cells after 72 hrs by MTT assay
|
[PMID: 24080103] |
| J774.1 | IC50 |
1 μM
Compound: Pentamidine
|
Cytotoxicity against mouse J774A.1 cells after 72 hrs by MTT assay
Cytotoxicity against mouse J774A.1 cells after 72 hrs by MTT assay
|
[PMID: 25846065] |
| J774.1 | IC50 |
38.6 μM
Compound: Pentamidine
|
Cytotoxicity against mouse J774.1 cells after 24 hrs by alamar blue assay
Cytotoxicity against mouse J774.1 cells after 24 hrs by alamar blue assay
|
[PMID: 28698054] |
| J774.A1 | CC50 |
0.56 μM
Compound: Pentamidine
|
Cytotoxicity against mouse J774A1 cells incubated for 72 hrs by MTT assay
Cytotoxicity against mouse J774A1 cells incubated for 72 hrs by MTT assay
|
[PMID: 25282267] |
| J774.A1 | CC50 |
0.56 μM
Compound: Pentamidine, Pentacarinat
|
Cytotoxicity against mouse J774A1 cells after 72 hrs by MTT assay
Cytotoxicity against mouse J774A1 cells after 72 hrs by MTT assay
|
[PMID: 24858543] |
| J774.A1 | CC50 |
1 μM
Compound: Pentamidine
|
Cytotoxicity against mouse J774A1 cells after 72 hrs by MTT assay
Cytotoxicity against mouse J774A1 cells after 72 hrs by MTT assay
|
[PMID: 22608675] |
| J774.A1 | CC50 |
25.15 μg/mL
Compound: Pentamidine
|
Cytotoxicity against mouse J774A1 cells after 72 hrs by MTT assay
Cytotoxicity against mouse J774A1 cells after 72 hrs by MTT assay
|
[PMID: 20457476] |
| J774.A1 | CC50 |
3.91 μg/mL
Compound: Pentamidine
|
Cytotoxicity against mouse J774A1 cells after 72 hrs by MTT assay
Cytotoxicity against mouse J774A1 cells after 72 hrs by MTT assay
|
[PMID: 20199824] |
| J774.A1 | CC50 |
31.31 μg/mL
Compound: Pentamidine
|
Cytotoxicity against mouse J774A1 cells after 48 hrs by Geimsa staining method
Cytotoxicity against mouse J774A1 cells after 48 hrs by Geimsa staining method
|
[PMID: 19091566] |
| J774.A1 | CC50 |
31.31 μg/mL
Compound: Pentamidine
|
Cytotoxicity against mouse J774A1 cells after 72 hrs by MTT assay
Cytotoxicity against mouse J774A1 cells after 72 hrs by MTT assay
|
[PMID: 19217698] |
| J774.A1 | CC50 |
31.31 μg/mL
Compound: Pentamidine
|
Cytotoxicity against mouse J774A1 cells by MTT assay
Cytotoxicity against mouse J774A1 cells by MTT assay
|
[PMID: 19913413] |
| J774.A1 | CC50 |
52.82 μM
Compound: Pentamidine
|
Cytotoxicity against mouse J774A1 cells after 72 hrs by MTT assay
Cytotoxicity against mouse J774A1 cells after 72 hrs by MTT assay
|
[PMID: 20371140] |
| J774.A1 | CC50 |
52.82 μM
Compound: Pentamidine
|
Toxicity in mouse J774A1 cells
Toxicity in mouse J774A1 cells
|
[PMID: 20850302] |
| J774.A1 | IC50 |
>20 μM
Compound: Pentamidine
|
Antileishmanial activity against intracellular amastigote stage of Leishmania infantum MHOM/MA/67/ITMAP-263 expressing luciferase infected in mouse J774A1 cells assessed as inhibition of metabolic activity after 120 hrs by luminescence assay
Antileishmanial activity against intracellular amastigote stage of Leishmania infantum MHOM/MA/67/ITMAP-263 expressing luciferase infected in mouse J774A1 cells assessed as inhibition of metabolic activity after 120 hrs by luminescence assay
|
[PMID: 25846065] |
| J774.A1 | IC50 |
1.03 μM
Compound: Pentamidine
|
Cytotoxic activity against mouse J774A1 cells after 72 hrs by MTT assay
Cytotoxic activity against mouse J774A1 cells after 72 hrs by MTT assay
|
[PMID: 21555166] |
| J774.A1 | IC50 |
12.11 μg/mL
Compound: Pentamidine
|
Antileishmanial activity against Leishmania donovani intracellular amastigotes infected in mouse J774A1 cells after 48 hrs by luciferase activity-based drug susceptibility assay
Antileishmanial activity against Leishmania donovani intracellular amastigotes infected in mouse J774A1 cells after 48 hrs by luciferase activity-based drug susceptibility assay
|
[PMID: 19091566] |
| J774.A1 | IC50 |
12.11 μg/mL
Compound: Pentamidine
|
Antileishmanial activity against Leishmania donovani MHOM/IN/Dd8 amastigotes infected in mouse J774A1 cells assessed as luciferase activity after 48 hrs
Antileishmanial activity against Leishmania donovani MHOM/IN/Dd8 amastigotes infected in mouse J774A1 cells assessed as luciferase activity after 48 hrs
|
[PMID: 19328690] |
| J774.A1 | IC50 |
12.11 μg/mL
Compound: Pentamidine
|
Antileishmanial activity against amastigote of Leishmania donovani MHOM/IN/80/Dd8 infected in mouse J774A1 cells after 72 hrs by luciferase reporter gene assay
Antileishmanial activity against amastigote of Leishmania donovani MHOM/IN/80/Dd8 infected in mouse J774A1 cells after 72 hrs by luciferase reporter gene assay
|
[PMID: 20457476] |
| J774.A1 | IC50 |
12.9 μg/mL
Compound: Pentamidine
|
Cytotoxicity against mouse J774A1 cells after 72 hrs by cell-titer assay
Cytotoxicity against mouse J774A1 cells after 72 hrs by cell-titer assay
|
[PMID: 15679330] |
| J774.A1 | IC50 |
13.68 μM
Compound: PM
|
Antileishmanial activity against amastigote stage of Leishmania donovani MHOM/IN/80/Dd8 infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay
Antileishmanial activity against amastigote stage of Leishmania donovani MHOM/IN/80/Dd8 infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay
|
[PMID: 24900613] |
| J774.A1 | IC50 |
20.43 μM
Compound: Pentamidine
|
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J774A1 cells assessed as inhibition of parasite growth after 72 hrs by luciferase reporter gene assay
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J774A1 cells assessed as inhibition of parasite growth after 72 hrs by luciferase reporter gene assay
|
[PMID: 20850302] |
| J774.A1 | IC50 |
3.59 μg/mL
Compound: Pentamidine
|
Antileishmanial activity against Leishmania donovani MHOM/IN/Dd8 amastigote carrying firefly luciferase gene infected in mouse J774A1 cells assessed as relative luminescence unit after 72 hrs
Antileishmanial activity against Leishmania donovani MHOM/IN/Dd8 amastigote carrying firefly luciferase gene infected in mouse J774A1 cells assessed as relative luminescence unit after 72 hrs
|
[PMID: 20199824] |
| KB | CC50 |
52.7 μM
Compound: Pentamidine
|
Cytotoxicity against human KB cells after 72 hrs by MTT assay
Cytotoxicity against human KB cells after 72 hrs by MTT assay
|
[PMID: 23182089] |
| KB | IC50 |
0.11 μg/mL
Compound: pentamidine
|
Cytotoxicity against human KB cells
Cytotoxicity against human KB cells
|
[PMID: 12398543] |
| L6 | IC50 |
1.51 μM
Compound: pentamidine
|
Cytotoxicity against rat L6 cells after 70 hrs by resazurin reduction assay
Cytotoxicity against rat L6 cells after 70 hrs by resazurin reduction assay
|
[PMID: 23301592] |
| L6 | IC50 |
2.1 μM
Compound: I
|
Cytotoxicity against rat L6 cells after 72 hrs by alamar blue staining-based microplate fluorometric analysis
Cytotoxicity against rat L6 cells after 72 hrs by alamar blue staining-based microplate fluorometric analysis
|
[PMID: 22005186] |
| L6 | IC50 |
2.1 μM
Compound: 1
|
Cytotoxicity against rat L6 cells
Cytotoxicity against rat L6 cells
|
[PMID: 16913722] |
| L6 | IC50 |
2100 nM
Compound: 1
|
Cytotoxicity against rat L6 cells assessed as cell viability after 70 hrs by Alamar blue assay
Cytotoxicity against rat L6 cells assessed as cell viability after 70 hrs by Alamar blue assay
|
[PMID: 24012380] |
| L6 | IC50 |
2100 nM
Compound: 1
|
Cytotoxicity against rat L6 cells
Cytotoxicity against rat L6 cells
|
[PMID: 19699098] |
| L6 | IC50 |
25 μM
Compound: Pentamidine
|
Cytotoxicity against rat L6 cells after 70 hrs by alamar blue assay
Cytotoxicity against rat L6 cells after 70 hrs by alamar blue assay
|
[PMID: 21112788] |
| L6 | IC50 |
3.8 μM
Compound: 24
|
Cytotoxicity against rat L6 cells
Cytotoxicity against rat L6 cells
|
[PMID: 20303767] |
| L6 | IC50 |
31.8 μM
Compound: Pentamidine
|
Cytotoxicity against rat L6 cells measured after 70 hrs by alamar blue staining based fluorescence analysis
Cytotoxicity against rat L6 cells measured after 70 hrs by alamar blue staining based fluorescence analysis
|
[PMID: 27102161] |
| L6 | IC50 |
46 μM
Compound: PNT
|
Cytotoxicity against rat L6 cells by Alamar blue assay
Cytotoxicity against rat L6 cells by Alamar blue assay
|
[PMID: 34146914] |
| L6 | IC50 |
46 μM
Compound: I
|
Cytotoxicity against rat L6 cells
Cytotoxicity against rat L6 cells
|
[PMID: 21421317] |
| L6 | IC50 |
46 μM
Compound: Pentamidine
|
Cytotoxicity against rat L6 cells
Cytotoxicity against rat L6 cells
|
[PMID: 20031421] |
| L6 | IC50 |
46.6 mM
Compound: PMD
|
Cytotoxicity against rat L6 cells after 72 hrs by Alamar blue assay
Cytotoxicity against rat L6 cells after 72 hrs by Alamar blue assay
|
[PMID: 23871911] |
| L6 | IC50 |
46.6 nM
Compound: Pentamidine
|
Cytotoxicity against rat L6 cells by alamar blue assay
Cytotoxicity against rat L6 cells by alamar blue assay
|
[PMID: 17178177] |
| L6 | IC50 |
46.6 μM
Compound: Pentamidine
|
Cytotoxicity against rat L6 cells after 3 days by Alamar blue assay
Cytotoxicity against rat L6 cells after 3 days by Alamar blue assay
|
[PMID: 24956553] |
| L6 | IC50 |
46.6 μM
Compound: PMD
|
Cytotoxicity against rat L6 cells after 70 hrs by alamar blue assay
Cytotoxicity against rat L6 cells after 70 hrs by alamar blue assay
|
[PMID: 19606902] |
| L6 | IC50 |
46.6 μM
Compound: PMD
|
Cytotoxicity against rat L6 cells after 70 hrs by alamar blue assay
Cytotoxicity against rat L6 cells after 70 hrs by alamar blue assay
|
[PMID: 19757840] |
| L6 | IC50 |
46.6 μM
Compound: PMD
|
Cytotoxicity against rat L6 cells after 70 hrs by alamar blue assay
Cytotoxicity against rat L6 cells after 70 hrs by alamar blue assay
|
[PMID: 19928900] |
| L6 | IC50 |
46.6 μM
Compound: PMD, Pentamidine
|
Cytotoxicity against rat L6 cells after 72 hrs by Alamar Blue assay
Cytotoxicity against rat L6 cells after 72 hrs by Alamar Blue assay
|
[PMID: 23795673] |
| L6 | IC50 |
46.6 μM
Compound: PMD, Pentamidine
|
Cytotoxicity against rat L6 cells assessed as cell viability after 70 hrs by Alamar blue assay
Cytotoxicity against rat L6 cells assessed as cell viability after 70 hrs by Alamar blue assay
|
[PMID: 24268543] |
| L6 | IC50 |
46.6 μM
Compound: I
|
Cytotoxicity against rat L6 cells
Cytotoxicity against rat L6 cells
|
[PMID: 20403703] |
| L6 | IC50 |
46.6 μM
Compound: PMD
|
Cytotoxicity against rat L6 cells
Cytotoxicity against rat L6 cells
|
[PMID: 17948982] |
| L6 | IC50 |
46.6 μM
Compound: PMD
|
Cytotoxicity against rat L6 cells
Cytotoxicity against rat L6 cells
|
[PMID: 18841956] |
| L6 | IC50 |
46.6 μM
Compound: PMD
|
Cytotoxicity against rat L6 cells
Cytotoxicity against rat L6 cells
|
[PMID: 19409677] |
| L6 | IC50 |
6 μM
Compound: Pentamidine
|
Cytotoxicity against rat L6 cells by alamar blue assay
Cytotoxicity against rat L6 cells by alamar blue assay
|
[PMID: 21194955] |
| LLC-MK2 | IC50 |
25.61 μM
Compound: Pentamidine
|
Cytotoxicity against rhesus monkey LLC-MK2 cells after 48 hrs by MTT assay
Cytotoxicity against rhesus monkey LLC-MK2 cells after 48 hrs by MTT assay
|
[PMID: 20934347] |
| Macrophage | CC50 |
10 μM
Compound: Pentamidine
|
Cytotoxicity against human THP-1 derived macrophages by colorimetric MTT assay
Cytotoxicity against human THP-1 derived macrophages by colorimetric MTT assay
|
[PMID: 35675511] |
| Macrophage | IC50 |
8.7 μg/mL
Compound: pentamidine
|
Cytotoxicity against human macrophages after 48 hrs by MTT assay
Cytotoxicity against human macrophages after 48 hrs by MTT assay
|
[PMID: 18177008] |
| Malme-3M | IC50 |
10.2 μM
Compound: SBi1
|
Growth inhibition of human MALME-3M cells overexpressing calcium-binding protein S100B after 4 days by SYBR green assay
Growth inhibition of human MALME-3M cells overexpressing calcium-binding protein S100B after 4 days by SYBR green assay
|
[PMID: 23264854] |
| Malme-3M | IC50 |
12.2 μM
Compound: SBi1
|
Growth inhibition of human MALME-3M cells transfected with S100B siRNA after 4 days by SYBR green assay
Growth inhibition of human MALME-3M cells transfected with S100B siRNA after 4 days by SYBR green assay
|
[PMID: 23264854] |
| MDCK-II | IC50 |
0.41 μM
Compound: pentamidine
|
Inhibition of human MATE1-mediated [14]-metformin uptake expressed in polarized MDCK2 cells after 5 mins by liquid scintillation counting analysis
Inhibition of human MATE1-mediated [14]-metformin uptake expressed in polarized MDCK2 cells after 5 mins by liquid scintillation counting analysis
|
[PMID: 23241029] |
| MRC5 | IC50 |
5.7 μg/mL
Compound: Pentamidine
|
Cytotoxicity against human MRC5 cells
Cytotoxicity against human MRC5 cells
|
[PMID: 24388808] |
| MRC5 | IC50 |
5.71 μg/mL
Compound: pentamidine
|
Cytotoxicity against human MRC5 cells after 7 days by MTT assay
Cytotoxicity against human MRC5 cells after 7 days by MTT assay
|
[PMID: 19013823] |
| Peritoneal macrophage | CC50 |
35.7 μM
Compound: Pentamidine
|
Cytotoxicity against mouse peritoneal macrophages assessed as decrease in cell viability after 24 hrs by MTT assay
Cytotoxicity against mouse peritoneal macrophages assessed as decrease in cell viability after 24 hrs by MTT assay
|
[PMID: 30913526] |
| Peritoneal macrophage | CC50 |
8.5 μM
Compound: Pentamidine
|
Cytotoxicity against Balb/c mouse peritoneal macrophages assessed as reduction in cell viability after 72 hrs by resazurin assay
Cytotoxicity against Balb/c mouse peritoneal macrophages assessed as reduction in cell viability after 72 hrs by resazurin assay
|
[PMID: 29459275] |
| Peritoneal macrophage cell | CC50 |
11.22 μM
Compound: Pentamidine
|
Cytotoxicity against mouse peritoneal macrophages assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Cytotoxicity against mouse peritoneal macrophages assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 26112378] |
| Peritoneal macrophage cell | CC50 |
26.3 μM
Compound: Pentamidine
|
Cytotoxicity against Swiss mouse peritoneal macrophages at 20 uM after 5 days by MTT assay
Cytotoxicity against Swiss mouse peritoneal macrophages at 20 uM after 5 days by MTT assay
|
[PMID: 23851117] |
| Peritoneal macrophage cell | CC50 |
3.82 μg/mL
Compound: Pentamidine
|
Cytotoxicity against mouse peritoneal macrophages after 72 hrs by MTT assay
Cytotoxicity against mouse peritoneal macrophages after 72 hrs by MTT assay
|
[PMID: 23623672] |
| Peritoneal macrophage cell | CC50 |
35.7 μM
Compound: Pentamidine
|
Cytotoxicity against Swiss albino mouse peritoneal macrophages after 24 hrs by MTT assay
Cytotoxicity against Swiss albino mouse peritoneal macrophages after 24 hrs by MTT assay
|
[PMID: 26169126] |
| Peritoneal macrophage cell | EC50 |
35.69 μM
Compound: Pent
|
Cytotoxicity against BALB/c mouse peritoneal macrophages incubated for 24 hrs by MTT assay
Cytotoxicity against BALB/c mouse peritoneal macrophages incubated for 24 hrs by MTT assay
|
[PMID: 26055530] |
| Peritoneal macrophage cell | IC50 |
152.7 μM
Compound: Pentamidine
|
Cytotoxicity against BALB/c mouse peritoneal macrophages assessed as cell viability after 48 hrs by trypan blue dye exclusion method
Cytotoxicity against BALB/c mouse peritoneal macrophages assessed as cell viability after 48 hrs by trypan blue dye exclusion method
|
[PMID: 26383125] |
| Peritoneal macrophage cell | IC50 |
30.4 μM
Compound: pentamidine
|
Cytotoxicity against mouse Peritoneal macrophages cells after 72 hrs by MTS assay
Cytotoxicity against mouse Peritoneal macrophages cells after 72 hrs by MTS assay
|
[PMID: 22989363] |
| RAW264.7 | CC50 |
>100 μM
Compound: Pentamidine
|
Cytotoxicity against mouse RAW264.7 cells assessed as cell growth inhibition after 72 hrs by Alamar blue dye-based assay
Cytotoxicity against mouse RAW264.7 cells assessed as cell growth inhibition after 72 hrs by Alamar blue dye-based assay
|
[PMID: 27793448] |
| RAW264.7 | CC50 |
25.5 μM
Compound: Pentamidine
|
Cytotoxicity against mouse RAW264.7 cells after 24 hrs by MTT assay
Cytotoxicity against mouse RAW264.7 cells after 24 hrs by MTT assay
|
[PMID: 24125880] |
| RAW264.7 | EC50 |
5.3 μg/mL
Compound: Pentamidine
|
Antileishmanial activity against axenically cultured Leishmania infantum chagasi MHOM/BR/00/1669 promastigotes infected in mouse RAW264.7 cells assessed as inhibition of parasite growth after 48 hrs
Antileishmanial activity against axenically cultured Leishmania infantum chagasi MHOM/BR/00/1669 promastigotes infected in mouse RAW264.7 cells assessed as inhibition of parasite growth after 48 hrs
|
[PMID: 25281268] |
| RAW264.7 | IC50 |
30 μM
Compound: pentamidine
|
Cytotoxicity against mouse RAW264.7 cells after 72 hrs by MTS assay
Cytotoxicity against mouse RAW264.7 cells after 72 hrs by MTS assay
|
[PMID: 22989363] |
| RAW264.7 | IC50 |
4.21 μM
Compound: Pentamidine
|
Antikinetoplastid activity against Leishmania donovani LV9 axenic amastigotes in mouse RAW264.7 cells assessed as viability measured 24 hrs by SYBR green assay
Antikinetoplastid activity against Leishmania donovani LV9 axenic amastigotes in mouse RAW264.7 cells assessed as viability measured 24 hrs by SYBR green assay
|
[PMID: 25499437] |
| THP-1 | CC50 |
<10 μM
Compound: Pentamidine
|
Cytotoxicity against human THP-1 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Cytotoxicity against human THP-1 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 39291018] |
| THP-1 | CC50 |
>10 μM
Compound: Pentamidine
|
Cytotoxicity against human THP-1 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
Cytotoxicity against human THP-1 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
|
[PMID: 35178179] |
| THP-1 | CC50 |
10 μM
Compound: PEN
|
Cytotoxicity against human THP1 cells assessed as decrease in viable cells after 72 hrs by MTT assay
Cytotoxicity against human THP1 cells assessed as decrease in viable cells after 72 hrs by MTT assay
|
[PMID: 29407968] |
| THP-1 | CC50 |
31.2 μM
Compound: Pentamidine
|
Cytotoxicity against human THP1 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Cytotoxicity against human THP1 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 25559208] |
| THP-1 | CC50 |
51.8 μM
Compound: Pentamidine
|
Cytotoxicity in human THP-1 cells assessed as reduction in cell viability incubated for 48 hrs hrs by MTT assay
Cytotoxicity in human THP-1 cells assessed as reduction in cell viability incubated for 48 hrs hrs by MTT assay
|
[PMID: 36105326] |
| THP-1 | EC50 |
15.8 μM
Compound: Pentamidine
|
Cytotoxicity against human THP-1 cells
Cytotoxicity against human THP-1 cells
|
[PMID: 30234295] |
| THP-1 | IC50 |
>10 μg/mL
Compound: Pentamidine
|
Cytotoxicity against human THP1 cells after 48 hrs by Alamar blue assay
Cytotoxicity against human THP1 cells after 48 hrs by Alamar blue assay
|
[PMID: 25240614] |
| THP-1 | IC50 |
>20 μM
Compound: Pentamidine
|
Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI intracellular amastigotes infected in human THP1 cells assessed as reduction in parasite-infected macrophages incubated for 120 hrs by Giemsa staining based microscopy
Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI intracellular amastigotes infected in human THP1 cells assessed as reduction in parasite-infected macrophages incubated for 120 hrs by Giemsa staining based microscopy
|
[PMID: 25559208] |
| THP-1 | IC50 |
>20 μM
Compound: Pentamidine
|
Antileishmanial activity against intracellular amastigote stage of Leishmania donovani MHOM/IN/00/DEVI infected in human THP1 cells assessed as decrease infected macrophages after 120 hrs by microscopy
Antileishmanial activity against intracellular amastigote stage of Leishmania donovani MHOM/IN/00/DEVI infected in human THP1 cells assessed as decrease infected macrophages after 120 hrs by microscopy
|
[PMID: 25846065] |
| THP-1 | IC50 |
0.4 μg/mL
Compound: Pentamidine
|
Antileishmanial activity against amastigote stage of Leishmania donovani infected in human THP1 cells after 48 hrs by Alamar blue assay
Antileishmanial activity against amastigote stage of Leishmania donovani infected in human THP1 cells after 48 hrs by Alamar blue assay
|
[PMID: 25240614] |
| THP-1 | IC50 |
1.6 nM
Compound: pentamidine
|
Antiparasitic activity against bloodstream form of Trypanosoma brucei brucei 427 infected in macrophages differentiated from human THP1 cells assessed as growth inhibition after 72 hrs by Alamar Blue assay
Antiparasitic activity against bloodstream form of Trypanosoma brucei brucei 427 infected in macrophages differentiated from human THP1 cells assessed as growth inhibition after 72 hrs by Alamar Blue assay
|
[PMID: 26322631] |
| THP-1 | IC50 |
10 μg/mL
Compound: PEN
|
Antileishmanial activity against wild-type Leishmania infantum MHOM/MA/67/ITMAP-263 promastigotes infected in human THP1 cells by luciferase based assay
Antileishmanial activity against wild-type Leishmania infantum MHOM/MA/67/ITMAP-263 promastigotes infected in human THP1 cells by luciferase based assay
|
[PMID: 17452480] |
| THP-1 | IC50 |
2 μM
Compound: Pentamidine
|
Antimicrobial activity against promastigote stage of Leishmania donovani infected in human THP1 cells after 72 hrs by Alamar Blue assay
Antimicrobial activity against promastigote stage of Leishmania donovani infected in human THP1 cells after 72 hrs by Alamar Blue assay
|
[PMID: 24980054] |
| THP-1 | IC50 |
31.2 μM
Compound: Pentamidine
|
Cytotoxicity against human THP1 cells after 72 hrs by flow cytometry
Cytotoxicity against human THP1 cells after 72 hrs by flow cytometry
|
[PMID: 20833057] |
| THP-1 | IC50 |
31.2 μM
Compound: Pentamidine
|
Cytotoxicity against human THP1 cells after 72 hrs by MTT assay
Cytotoxicity against human THP1 cells after 72 hrs by MTT assay
|
[PMID: 25846065] |
| THP-1 | IC50 |
5.1 μg/mL
Compound: PEN
|
Antileishmanial activity against wild-type Leishmania major LV39 promastigotes infected in human THP1 cells by luciferase based assay
Antileishmanial activity against wild-type Leishmania major LV39 promastigotes infected in human THP1 cells by luciferase based assay
|
[PMID: 17452480] |
| THP-1 | IC50 |
6.8 μg/mL
Compound: PEN
|
Antileishmanial activity against wild-type Leishmania amazonensis MHOM/BR/1973/MM2269 promastigotes infected in human THP1 cells by luciferase based assay
Antileishmanial activity against wild-type Leishmania amazonensis MHOM/BR/1973/MM2269 promastigotes infected in human THP1 cells by luciferase based assay
|
[PMID: 17452480] |
| THP-1 | IC50 |
7.02 μM
Compound: Pentamidine
|
Antileishmanial activity against Leishmania major JISH118 promastigotes infected in human THP1 cells by Giemsa staining method
Antileishmanial activity against Leishmania major JISH118 promastigotes infected in human THP1 cells by Giemsa staining method
|
[PMID: 25069019] |
| THP-1 | IC50 |
7.7 μM
Compound: Pentamidine
|
Cytotoxicity against human THP1 cells
Cytotoxicity against human THP1 cells
|
[PMID: 28012342] |
| U-937 | IC50 |
6.02 μM
Compound: Pentamidine
|
Cytotoxicity against human U937 cells
Cytotoxicity against human U937 cells
|
[PMID: 28012342] |
| Vero | CC50 |
47 μM
Compound: Pentamidine
|
Cytotoxicity against african green monkey Vero cells after 72 hrs by MTT assay
Cytotoxicity against african green monkey Vero cells after 72 hrs by MTT assay
|
[PMID: 21397502] |
| Vero | CC50 |
47 μM
Compound: Pentamidine
|
Cytotoxicity against African green monkey Vero cells assessed as cell viability after 48 hrs by SRB assay
Cytotoxicity against African green monkey Vero cells assessed as cell viability after 48 hrs by SRB assay
|
[PMID: 24529307] |
| Vero | CC50 |
47 μM
Compound: Pentamidine
|
Cytotoxicity against African green monkey Vero cells incubated for 24 to 48 hrs by SRB assay
Cytotoxicity against African green monkey Vero cells incubated for 24 to 48 hrs by SRB assay
|
[PMID: 28645659] |
| Vero | CC50 |
85.86 μM
Compound: PM
|
Cytotoxicity against African green monkey Vero cells assessed as cell viability after 72 hrs by MTT assay
Cytotoxicity against African green monkey Vero cells assessed as cell viability after 72 hrs by MTT assay
|
[PMID: 24900613] |
| Vero | IC50 |
>100 μM
Compound: 3
|
Cytotoxicity against african green monkey Vero cells by neutral red assay
Cytotoxicity against african green monkey Vero cells by neutral red assay
|
[PMID: 18367395] |
| Vero | IC50 |
>50 μg/mL
Compound: Pentamidine
|
Cytotoxicity against african green monkey Vero cells after 72 hrs by cell-titer assay
Cytotoxicity against african green monkey Vero cells after 72 hrs by cell-titer assay
|
[PMID: 15679330] |
| Vero | IC50 |
13.7 μM
Compound: Pentamidine
|
Cytotoxicity against african green monkey Vero cells
Cytotoxicity against african green monkey Vero cells
|
[PMID: 17880175] |
| Vero | IC50 |
57 μM
Compound: Pentamidine
|
Cytotoxicity against african green monkey Vero cells assessed as growth inhibition after 72 hrs by MTS assay
Cytotoxicity against african green monkey Vero cells assessed as growth inhibition after 72 hrs by MTS assay
|
[PMID: 23727538] |
| WM-115 | EC50 |
16.3 μM
Compound: 4b
|
Growth inhibition of human WM115 cells expressing high levels of S100-B by SYBR Green based fluorescence method
Growth inhibition of human WM115 cells expressing high levels of S100-B by SYBR Green based fluorescence method
|
[PMID: 26727270] |
| WM-115 | EC50 |
16.7 μM
Compound: 4b
|
Growth inhibition of human WM115 cells expressing low levels of S100-B by SYBR Green based fluorescence method
Growth inhibition of human WM115 cells expressing low levels of S100-B by SYBR Green based fluorescence method
|
[PMID: 26727270] |
| WM-115 | IC50 |
4.8 μM
Compound: pentamidine
|
Cytotoxicity against human WM115 cells assessed as growth inhibition measured after 72 hrs by crystal violet assay
Cytotoxicity against human WM115 cells assessed as growth inhibition measured after 72 hrs by crystal violet assay
|
[PMID: 23375094] |
Pentamidine (0-10 µg/mL; 6 days; WM9, DU145, C4-2, Hey, WM480, and A549 cells) treatment inhibits the growth of cancer cells in a concentration-dependent manner[1].
The cytotoxic properties of Pentamidine isethionate towards the promastigotes of the protozoan parasite Leishmania infantum is determined. The leishmanicidal activity of Pentamidine isethionate is 60 times higher after 72 h of incubation than that of Cisplatin. Pentamidine isethionate induces a higher amount of programmed cell death (PCD) than Cisplatin, which is associated with inhibition of DNA synthesis and cell-cycle arrest in the G2/M phase. Binding of Pentamidine isethionate to calf-thymus DNA (CT-DNA) induces conformational changes in the DNA double helix, consistent with a B-->A transition. The interaction of Pentamidine isethionate with ubiquitin leads to a 6% increase in the beta-sheet content of the protein[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:WM9, DU145, C4-2, Hey, WM480, and A549 cells
-
Concentration:0-10 µg/mL
-
Incubation Time:6 days
-
Result:The growth of all six of the cell lines in culture was inhibited in a concentration-dependent manner with complete growth inhibition of the cell lines occurring at 10 µg/mL.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Athymic nude mice (6 weeks old) injected with WM9 cells[1]
-
Dosage:0.25 mg/mouse
-
Administration:Intramuscular injection; every 2 days; for 4 weeks
-
Result:Markedly inhibited the growth of WM9 human melanoma tumors in nude mice.
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
CAS No. 100-33-4
-
Appearance Solid
-
Masse moléculaire 340.42
-
Formule C19H24N4O2
-
Color White to off-white
-
SMILES
N=C(C1=CC=C(OCCCCCOC2=CC=C(C(N)=N)C=C2)C=C1)N
-
Synonyms
MP-601205
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
Publications (9)
-
Journal Impact Factor
-
Most Recent
-
Nature
2026 Jul;655(8121):240-250. PMID: 42236947 -
Immunity
Spermine enhances antiviral and anticancer responses by stabilizing DNA binding with the DNA sensor cGAS. [Abstract]2023 Feb 14;56(2):272-288.e7. PMID: 36724787 -
Drug Des Devel Ther
Pentamidine Inhibits Ovarian Cancer Cell Proliferation and Migration by Maintaining Stability of PTEN in vitro. [Abstract]2021 Jul 1;15:2857-2868. PMID: 34234416
Pentamidine purchased from MedChemExpress. Usage Cited in: Drug Des Devel Ther. 2021 Jul 1;15:2857-2868. [Abstract]
HO8910 cells were seeded in 96-well plates and treated with different concentrations of Pentamidine (0, 1, 2.5, 5.0, 7.5, 15, 20 μmol/L) for 24 hours, with three replicates for each concentration. Cell viability was then assessed after incubation with 20 μL of MTS for 1 hour.
Pentamidine purchased from MedChemExpress. Usage Cited in: Drug Des Devel Ther. 2021 Jul 1;15:2857-2868. [Abstract]
Scratch healing experiments were performed using DMSO control and Pentamidin-treated HO8910 cells. Representative images were obtained at specified time points at a concentration of 2.5 μmol/L.
Pentamidine purchased from MedChemExpress. Usage Cited in: Drug Des Devel Ther. 2021 Jul 1;15:2857-2868. [Abstract]
HO8910 and Caov3 cells were treated with different concentrations of Pentamidine (5/10/20 μM) for 24 hours. Cell lysates were collected and analyzed by Western blotting using anti-PTEN antibody. GAPDH was used as an internal control.
Pentamidine purchased from MedChemExpress. Usage Cited in: Drug Des Devel Ther. 2021 Jul 1;15:2857-2868. [Abstract]
HO8910 and Caov3 cells were treated with 20 μmol/L Pentamidine for 24 hours. PTEN mRNA levels were detected by RT-PCR and normalized to 18S rRNA levels.
-
Int J Mol Sci
The Properties of Linezolid, Rifampicin, and Vancomycin, as Well as the Mechanism of Action of Pentamidine, Determine Their Synergy against Gram-Negative Bacteria. [Abstract]2023 Sep 7;24(18):13812. PMID: 37762115 -
Molecules
In Vitro and in Vivo Activity of mTOR Kinase and PI3K Inhibitors Against Leishmania donovani and Trypanosoma brucei. [Abstract]2020 Apr 23;25(8):1980. PMID: 32340370
Pentamidine purchased from MedChemExpress. Usage Cited in: Molecules. 2020 Apr 23;25(8):1980. [Abstract]
In vivo results for T. brucei mouse model of infection. Mouse survival after treatment with 30 mg/kg pentamidine (solid green line), 15 mg/kg Torin2 (solid black line), 5 mg/kg NVP-BGT226 (dotted black line), or the PBS control (solid blue line) for 5 days.
-
Cell Rep Methods
RECOVER identifies synergistic drug combinations in vitro through sequential model optimization. [Abstract]2023 Oct 23;3(10):100599. PMID: 37797618 -
Microbiol Spectr
When Combined with Pentamidine, Originally Ineffective Linezolid Becomes Active in Carbapenem-Resistant Enterobacteriaceae. [Abstract]2023 Jun 15;11(3):e0313822. PMID: 37125928 -
BMC Womens Health
Pentamidine inhibits proliferation, migration and invasion in endometrial cancer via the PI3K/AKT signaling pathway. [Abstract]2022 Nov 24;22(1):470. PMID: 36434592
Pentamidine purchased from MedChemExpress. Usage Cited in: BMC Womens Health. 2022 Nov 24;22(1):470. [Abstract]
Pentamidine (2.5, 5 μM; 24-36 h) reduces cell migration in a dose- and time-dependent manner, in Ishikawa and HEC-1A cells.
-
Biochem Biophys Res Commun
Pentamidine protects mice from cecal ligation and puncture-induced brain damage via inhibiting S100B/RAGE/NF-κB. [Abstract]2019 Sep 17;517(2):221-226. PMID: 31331643
Solvant et solubilité
DMSO : 3.3 mg/mL (9.69 mM; ultrasonic and warming and adjust pH to 6 with 1 M HCl and heat to 60°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
1 M HCl : 2 mg/mL (5.88 mM; ultrasonic and warming and heat to 60°C)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Pureté et documentation
-
Fiche technique (283 KB)
-
SDS (394 KB)
- English - EN (394 KB)
- Français - FR (394 KB)
- Deutsch - DE (394 KB)
- Norwegian - NO (394 KB)
- Español - ES (394 KB)
- Swedish - SV (394 KB)
- Italian - IT (394 KB)
- Korean - KR (394 KB)
- Portuguese - PT (394 KB)
-
Instruction de manipulation (2659 KB)
Références
[1]. Pathak MK, et al. Pentamidine is an inhibitor of PRL phosphatases with anticancer activity. Mol Cancer Ther. 2002 Dec;1(14):1255-64. [Content Brief]
[2]. Nguewa, P.A., et al., Pentamidine is an antiparasitic and apoptotic drug that selectively modifies ubiquitin. Chem Biodivers, 2005. 2(10): p. 1387-400. [Content Brief]
[3]. Sands M, et al. Pentamidine: a review. Rev Infect Dis. 1985 Sep-Oct;7(5):625-34. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| 1 M HCl / DMSO | 1 mM | 2.9375 mL | 14.6877 mL | 29.3755 mL | 73.4387 mL |
| 5 mM | 0.5875 mL | 2.9375 mL | 5.8751 mL | 14.6877 mL |